Kaiser Asks To Admit 'Snake Oil' Barb In Neurontin Trial

By Hilary Russ

Law360, New York (March 15, 2010, 3:52 PM ET) -- Plaintiffs in a trial over off-label marketing of Neurontin are asking the court to let them admit evidence that a Pfizer Inc.-employed doctor called the drug “the 'snake oil' of the 20th century.”

In the request, filed Sunday in the U.S. District Court for the District of Massachusetts, Kaiser Foundation Health Plan Inc. and Kaiser Foundation Hospitals said they should be able to admit the “snake oil e-mail,” sent in 1999 by Christopher Wohlberg, which the defendants allegedly did not produce for Kaiser during discovery in...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles